Skip to main content
$212.68 -$0.32 (-0.2%)

04:00 PM EDT on 05/12/21

Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 4 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Current Price $212.68 Mkt Cap $55.1B
Open $212.06 P/E Ratio 20.00
Prev. Close $212.68 Div. (Yield) $0.00 (0.0%)
Daily Range $211.74 - $215.67 Volume 1,198,051
52-Wk Range $202.57 - $306.08 Avg. Daily Vol. 1,614,421

Caps

How do you think NASDAQ:VRTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

819 Outperform
69 Underperform
 

All-Star Players

198 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VRTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFAdriaCimino (28.68)
Submitted February 20, 2020

Vertex's earnings growth since 2016 as well as its development of non-opioid pain management drugs are reasons to be bullish.

MichaelHamilton (65.90)
Submitted June 25, 2014

$22bn,really??

NASDAQ:VRTX VS S&P 500 (SPY)

Fools bullish on NASDAQ:VRTX are also bullish on:

Fools bearish on NASDAQ:VRTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VRTX.

Recs

0
Member Avatar CMFJoeFoolery (< 20) Submitted: 4/5/2021 4:38:48 PM : Outperform Start Price: $215.50 NASDAQ:VRTX Score: -1.22

-Bullishness on gene therapy segment and partnership w/ CRISPR
-Strength in Cystic Fibrosis treatment (Dominant, but large part of US TAM left to capture)
-Research methodology/product development strategy
-Current valuation and multiples. ($55Bn, attractive growth in revenue and net income the past few yrs, plenty of cash on hand)

Recs

0
Member Avatar Garto (< 20) Submitted: 2/17/2021 5:37:16 PM : Outperform Start Price: $209.58 NASDAQ:VRTX Score: -2.58

Developing pills over a shot ,makes them a leader with 60% of people

Recs

0
Member Avatar SpartanMAC (38.37) Submitted: 11/12/2020 7:09:37 AM : Outperform Start Price: $217.05 NASDAQ:VRTX Score: -16.03

EY of 5.2%. Consistently growing earnings, sales, and free cash flow. Selling below intrinsic value even if growth estimates are cut in half.

Leaderboard

Find the members with the highest scoring picks in VRTX.

Score Leader

bugeyebear

bugeyebear (25.80) Score: +1,125.73

The Score Leader is the player with the highest score across all their picks in VRTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
bugeyebear 25.80 3/17/2008 Outperform 3Y $14.60 +1,356.71% +230.98% +1,125.73 0 Comment
lostontheprairie 68.63 3/12/2008 Outperform 5Y $14.99 +1,318.81% +218.31% +1,100.51 0 Comment
Kudude 71.95 3/12/2008 Outperform 5Y $14.99 +1,318.81% +218.31% +1,100.51 0 Comment
Salilp 75.00 3/17/2008 Outperform 5Y $15.07 +1,311.28% +233.81% +1,077.47 0 Comment
davidmouw2 < 20 3/14/2008 Outperform NS $15.43 +1,278.35% +218.21% +1,060.14 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. snazzysnazz 71.15 3/13/2008 Outperform 5Y $15.49 +1,273.01% +225.99% +1,047.02 0 Comment
NovaMechanika 21.16 3/20/2008 Outperform 3Y $15.55 +1,267.72% +223.29% +1,044.43 2 Comments
stnewbie 53.30 3/12/2008 Outperform NS $15.78 +1,247.78% +219.75% +1,028.03 0 Comment
PrincetonAl 90.39 3/7/2008 Outperform 3Y $15.86 +1,240.98% +225.94% +1,015.05 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 71.96 3/24/2008 Outperform 5Y $16.47 +1,191.32% +215.37% +975.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VRTX.